Ganglioside based vaccine compositions for subcutaneous administration

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8591917
APP PUB NO 20070148181A1
SERIAL NO

10547164

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Vaccine compositions in which gangliosides and the OMP of N. meningitidis were combined to form very small size proteoliposomes (VSSP) to be administered subcutaneously are described, these compositions do not require the use of any additional adjuvant.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRO DE INMUNOLOGIA MOLECULARCALLE 216 Y 15 ATABEY PLAYA LA HABANA HABANA 11 300

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Molina, Luis Enrique Fernández Ciudad de la Habana, CU 2 1
Pardillo, Circe Mesa Ciudad de la Habana, CU 2 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 26, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00